Home Newsfeeds JMP Securities Downgrades Duck Creek Technologies to Market Perform

JMP Securities Downgrades Duck Creek Technologies to Market Perform

JMP Securities analyst Joe Goodwin downgrades Duck Creek Technologies (NASDAQ:DCT) from Market Outperform to Market Perform.

byBenzinga Newsdesk

July 1, 2022

1 minute read

JMP Securities analyst Joe Goodwin downgrades Duck Creek Technologies (NASDAQ:DCT) from Market Outperform to Market Perform.

Chinese Hotel Management Company H World’s Q3 Sales Jump, Thanks To Summer Holiday Travel Season & Business Travel Recovery

By Anusuya Lahiri

November 24, 9:13 AM

H World Group Ltd (NASDAQ: HTHT) reported third-quarter FY23 sales growth of 53.6% year-on-year to RMB6.3 billion ($861 million),

HTHT

Why Biometric Solutions Provider BIO-key Shares Are Trading Higher Today

By Lekha Gupta

December 27, 8:16 AM

BIO-key International Inc (NASDAQ: BKYI) disclosed Carrefour (OTC: CRRFY) is integrating the AuthControl Sentry cloud solution in Spain in partnership with Evolutio, BIO-key's

BKYI

Mark Zuckerberg’s Meta Working On A More Private ‘Flipside’ Instagram Experience So You Can Post More Candid Photos With Your Friends

By Rounak Jain

January 26, 7:25 AM

Instagram "Flipside" feature will allow users to create a more private feed where they can share photos with a select group of people.

Biofrontera Inc. Announces Last Patient Out In Phase I Study To Evaluate Safety And Tolerability In Treating Actinic Keratosis Using 3 Tubes Of Ameluz(R)

By Happy Mohamed

April 26, 10:06 AM

Biofrontera Inc. (NASDAQ:BFRI), a biopharmaceutical company specializing in the commercialization of dermatological products, today announced that that the last patient in a Phase I study to evaluate the safety and

BFRI

JMP Securities Downgrades Duck Creek Technologies to Market Perform

Related Posts

Chinese Hotel Management Company H World’s Q3 Sales Jump, Thanks To Summer Holiday Travel Season & Business Travel Recovery

Why Biometric Solutions Provider BIO-key Shares Are Trading Higher Today

Mark Zuckerberg’s Meta Working On A More Private ‘Flipside’ Instagram Experience So You Can Post More Candid Photos With Your Friends

Biofrontera Inc. Announces Last Patient Out In Phase I Study To Evaluate Safety And Tolerability In Treating Actinic Keratosis Using 3 Tubes Of Ameluz(R)